Dr. Buell said the ARDS trial is designed for rapid, clinically oriented readouts: "we think we will have early readouts quite quickly, and we're setting up already to be publicly presenting these ...

The study concluded that NEXGEL’s hydrogel patch significantly reduced laser plume generation and exposure during laser hair removal and the patch was associated with greater hair reduction and ...

Process industries say it's quality data, not randomly gathered data mountains, that matter in the age of industrial AI. Its ...

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today ...

A Cleveland Clinic study suggests GLP-1 weight loss drugs may help slow the spread of some obesity-related cancers.

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') today announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) will be ...

Phison Electronics (8299TT), a global leader in NAND flash controllers and storage solutions, today announced that its Pascari D206V PCIe Gen5 data center SSD has received the prestigious COMPUTEX ...

The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during ...

Helen Pearson’s “Beyond Belief” profiles figures who propelled medicine and other fields toward evidence-based thinking.

A statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the ...

Pieter Martens, MD, PhD (Hospital Oost-Limburg, Genk, Belgium), who made the “pro” case on behalf of IV iron, pointed out ...